Nutriband Inc.
General ticker "NTRB" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $67.1M (TTM average)
Nutriband Inc. does not follow the US Stock Market performance with the rate: -28.9%.
Estimated limits based on current volatility of 2.9%: low 3.42$, high 3.63$
Factors to consider:
- Total employees count: 150 as of 2017
- US accounted for 100.0% of revenue in the fiscal year ended 2024-01-31
- Top business risk factors: No commercial products, Funding dependency, FDA approval delays, Clinical trial success, Regulatory and compliance
- Price in estimated range
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2026-01-31 to 2028-01-31
- 2026-01-31 to 2027-01-31 estimated range: [2.44$, 6.17$]
- 2027-01-31 to 2028-01-31 estimated range: [2.04$, 5.27$]
Financial Metrics affecting the NTRB estimates:
- Positive: with PPE of -1.9 at the end of fiscal year the price was neutral
- Negative: negative Operating cash flow
- Negative: negative Operating income
- Negative: negative Net income
- Positive: Investing cash flow per share per price, % of -0.01 > -0.60
- Positive: Shareholder equity ratio, % of 88.49 > 64.29
- Positive: Inventory ratio change, % of -2.67 <= -0.75
- Positive: Interest expense per share per price, % of 0.04 <= 0.73
Short-term NTRB quotes
Long-term NTRB plot with estimates
Financial data
| YTD | 2024-01-31 | 2025-01-31 | 2026-01-31 |
|---|---|---|---|
| Operating Revenue | $2.09MM | $2.14MM | $2.04MM |
| Operating Expenses | $6.96MM | $12.42MM | $10.35MM |
| Operating Income | $-4.87MM | $-10.28MM | $-8.32MM |
| Non-Operating Income | $-0.61MM | $-0.20MM | $0.09MM |
| Interest Expense | $0.08MM | $0.02MM | $0.02MM |
| R&D Expense | $1.96MM | $3.12MM | $1.89MM |
| Income(Loss) | $-5.49MM | $-10.48MM | $-8.23MM |
| Net Income(Loss)* | $-5.49MM | $-10.48MM | $-8.23MM |
| Stockholders Equity | $6.44MM | $6.43MM | $6.68MM |
| Inventory | $0.17MM | $0.21MM | $0.12MM |
| Assets | $7.52MM | $7.47MM | $7.55MM |
| Operating Cash Flow | $-3.53MM | $-4.63MM | $-5.13MM |
| Capital expenditure | $0.05MM | $0.09MM | $0.01MM |
| Investing Cash Flow | $-0.05MM | $-0.09MM | $-0.01MM |
| Financing Cash Flow | $2.09MM | $8.54MM | $5.40MM |
| Earnings Per Share** | $-0.69 | $-0.99 | $-0.71 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.